Surgery Partners (NASDAQ:SGRY) Posts Earnings Results

Surgery Partners (NASDAQ:SGRY) released its earnings results on Monday. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06), Briefing.com reports. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business had revenue of $821.50 million for the quarter, compared to analysts’ expectations of $823.55 million. During the same quarter in the previous year, the business posted $0.19 earnings per share. Surgery Partners’s revenue for the quarter was up 6.6% on a year-over-year basis. Surgery Partners updated its FY 2025 guidance to EPS.

Surgery Partners Trading Down 24.0%

Surgery Partners stock traded down $5.16 during trading hours on Monday, hitting $16.34. The company had a trading volume of 3,918,663 shares, compared to its average volume of 1,372,712. The firm has a market cap of $2.09 billion, a P/E ratio of -11.42 and a beta of 1.85. The company has a 50-day moving average price of $21.62 and a two-hundred day moving average price of $22.18. Surgery Partners has a 1 year low of $16.31 and a 1 year high of $31.89. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93.

Insider Buying and Selling

In other Surgery Partners news, insider Harrison R. Bane sold 9,339 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total value of $209,940.72. Following the completion of the sale, the insider directly owned 117,181 shares in the company, valued at approximately $2,634,228.88. This represents a 7.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Surgery Partners

A number of institutional investors have recently bought and sold shares of SGRY. JPMorgan Chase & Co. lifted its holdings in Surgery Partners by 67.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 323,932 shares of the company’s stock valued at $7,010,000 after purchasing an additional 130,392 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in Surgery Partners by 128.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock valued at $58,000 after acquiring an additional 1,519 shares during the period. Headlands Technologies LLC boosted its stake in shares of Surgery Partners by 101.8% in the second quarter. Headlands Technologies LLC now owns 16,556 shares of the company’s stock valued at $368,000 after purchasing an additional 8,353 shares during the period. CANADA LIFE ASSURANCE Co lifted its holdings in Surgery Partners by 26.2% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,927 shares of the company’s stock worth $422,000 after buying an additional 3,929 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in Surgery Partners by 68.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock worth $207,000 after acquiring an additional 3,794 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on SGRY. JPMorgan Chase & Co. initiated coverage on Surgery Partners in a research report on Thursday, September 18th. They set a “neutral” rating and a $27.00 price objective for the company. Bank of America started coverage on shares of Surgery Partners in a report on Monday, July 28th. They set a “buy” rating and a $28.00 price target on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $36.00 price objective on shares of Surgery Partners in a research report on Tuesday, October 7th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Surgery Partners in a report on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $31.14.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.